Meditera Tibbi Malzeme Sanayi ve Ticaret AS (IS:MEDTR) — Stock Price

TL25.50 TRY
▲ 0.95% today

Meditera Tibbi Malzeme Sanayi ve Ticaret AS (IS:MEDTR) is currently trading at TL25.50 TRY, up 0.95% today. Over the past 52 weeks, shares have ranged between TL25.08 and TL37.54. This page tracks Meditera Tibbi Malzeme Sanayi ve Ticaret AS's live share price on the IS exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Meditera Tibbi Malzeme Sanayi ve Ticaret.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Meditera Tibbi Malzeme Sanayi ve Ticaret AS's daily closing share price and trading volume on the IS exchange over the past year, giving a clear view of recent price momentum and liquidity.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Income Statement — Revenue, Profit & Earnings by Year

Meditera Tibbi Malzeme Sanayi ve Ticaret AS's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue TL2.87 Billion TL2.74 Billion TL2.10 Billion TL806.04 Million TL375.93 Million
Cost of Revenue TL2.00 Billion TL1.66 Billion TL1.17 Billion TL434.64 Million TL210.18 Million
Gross Profit TL875.84 Million TL1.08 Billion TL929.40 Million TL371.40 Million TL165.75 Million
Research & Development TL29.28 Million TL30.29 Million TL20.07 Million TL3.59 Million TL2.45 Million
SG&A TL247.43 Million TL240.30 Million TL165.08 Million TL63.46 Million TL30.29 Million
Total Operating Expenses TL2.76 Billion TL2.42 Billion TL1.71 Billion TL573.96 Million TL285.90 Million
Operating Income TL114.86 Million TL321.81 Million TL384.66 Million TL232.08 Million TL90.03 Million
EBITDA — — — TL365.13 Million TL227.34 Million
EBIT — — — TL228.26 Million TL89.09 Million
Interest Expense TL47.36 Million TL96.55 Million TL76.10 Million TL21.90 Million TL13.37 Million
Income Before Tax TL-16.10 Million TL95.03 Million TL80.26 Million TL331.64 Million TL202.10 Million
Income Tax Expense — — — TL34.62 Million TL34.40 Million
Net Income TL-9.27 Million TL96.11 Million TL37.35 Million TL297.05 Million TL167.70 Million

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Meditera Tibbi Malzeme Sanayi ve Ticaret AS's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets TL3.59 Billion TL3.68 Billion TL2.73 Billion TL1.10 Billion TL719.21 Million
Total Current Assets TL1.82 Billion TL2.03 Billion TL1.56 Billion TL720.12 Million TL618.34 Million
Cash & Equivalents — — — — —
Short-term Investments TL70.46 Million TL172.55 Million TL397.22 Million TL266.08 Million TL133.29 Million
Net Receivables TL760.92 Million TL558.24 Million TL418.45 Million TL257.51 Million TL130.45 Million
Inventory TL550.44 Million TL694.33 Million TL397.63 Million TL157.13 Million TL66.61 Million
Property, Plant & Equipment — — — TL301.67 Million TL85.24 Million
Goodwill TL64.54 Million TL0.00 — — —
Total Liabilities TL661.10 Million TL752.75 Million TL596.54 Million TL212.41 Million TL149.84 Million
Total Current Liabilities TL541.53 Million TL601.28 Million TL411.08 Million TL144.92 Million TL127.04 Million
Long-term Debt TL11.43 Million TL25.80 Million TL65.36 Million TL36.90 Million TL6.43 Million
Net Debt — — — — —
Total Stockholder Equity TL2.91 Billion TL2.92 Billion TL2.13 Billion TL885.61 Million TL569.37 Million
Retained Earnings TL645.37 Million TL695.50 Million TL506.30 Million TL484.95 Million TL327.90 Million

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Meditera Tibbi Malzeme Sanayi ve Ticaret AS generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow TL435.35 Million TL780.69 Million TL801.02 Million TL5.10 Million TL36.64 Million
Capital Expenditures TL191.67 Million TL263.52 Million TL299.70 Million TL51.35 Million TL8.92 Million
Free Cash Flow TL243.68 Million TL517.17 Million TL501.32 Million TL-46.87 Million TL27.42 Million
Investing Cash Flow — — — TL-43.44 Million TL-6.33 Million
Financing Cash Flow — — — TL-125.18 Million TL174.51 Million
Dividends Paid TL37.77 Million TL45.31 Million TL150.00 Million TL140.00 Million TL140.00 Million
Stock-Based Compensation — — TL-197.49K TL-309.10K —
Depreciation TL176.42 Million TL115.59 Million TL75.63 Million TL11.60 Million TL11.87 Million
Change in Cash TL-173.07 Million TL25.04 Million TL-84.23 Million TL-163.52 Million TL204.82 Million

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Earnings History — EPS Actual vs. Analyst Estimates

Track Meditera Tibbi Malzeme Sanayi ve Ticaret AS's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 31, 2026 -0.46 — —
Dec 31, 2025 0.55 — —
Sep 30, 2025 0.22 — —
Jun 30, 2025 -0.16 — —
Mar 31, 2025 -0.59 — —
Dec 31, 2024 0.11 — —
Sep 30, 2024 0.15 — —
Jun 30, 2024 0.23 — —